Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.75 |
| ▸ | AURKA | O14965 | 1/20 | 0.59 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.59 |
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.48 |
| ▸ | SENP1 | Q9P0U3 | 5/20 | 0.48 |
| ▸ | SENP3 | Q9H4L4 | 4/20 | 0.48 |
| ▸ | SUMO2 | P61956 | 4/20 | 0.48 |
| ▸ | SUMO1 | P63165 | 4/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 4/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.47 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.44 |
| ▸ | NSD2 | O96028 | 3/20 | 0.42 |
| ▸ | COMT | P21964 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9649777 | 1.00 | TTR (0.75) | TTRAURKAAURKBSENP2SENP1 | |
| SCHEMBL29516385 | 0.98 | TTR (0.78) | TTRAURKAAURKBSENP2SENP1 | |
| SCHEMBL1525888 | 0.98 | TTR (0.78) | TTRAURKAAURKBSENP2SENP1 | |
| SCHEMBL150853 | 0.98 | TTR (0.78) | TTRAURKAAURKBSENP2SENP1 | |
| SCHEMBL2093553 | 0.96 | TTR (0.75) | TTRAURKAAURKBSENP2SENP1 | |
| Nitrogen SCHEMBL28283073 | 0.94 | TTR (0.72) | TTRAURKAAURKBSENP2SENP1 | |
| SCHEMBL29044433 | 0.88 | TTR (0.64) | TTRAURKAAURKBSENP2SENP1 | |
| SCHEMBL147103 | 0.86 | TTR (1.00) | TTRAURKAAURKBIDO1CYP1A2 | |
| SCHEMBL29518656 | 0.86 | TTR (1.00) | TTRAURKAAURKBIDO1CYP1A2 | |
| SCHEMBL30804445 | 0.86 | TTR (1.00) | TTRAURKAAURKBIDO1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119368337-A | Copper-molybdenum collector and preparation method and application thereof | 昆明冶金研究院有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-221310035-U | Green preparation system of 1-amino-4-sodium naphthalene sulfonate | 三门峡新鑫源科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-112808036-A | Gas dehumidification film and preparation method and application thereof | 中国科学院过程工程研究所 | 2021-05-18 | — | — | CN | claimed |
| US-20100310755-A1 | ULTRA-SENSITIVE DETECTION OF FAINT FINGERPRINTS ON ROUGH SURFACES AND CORRESPONDING FINGERPRINT DETECTION KIT | Appealing Products, Inc. (US) | 2010-12-09 | — | — | US | claimed |
| US-20090306132-A1 | USE OF DERIVATIVES OF NAPHTHALENESULPHONIC OR QUINOLINESULPHONIC ACID IN THE TREATMENT OF VASOPROLIFERATIVE OCULAR DISEASES | ITALFARMACO, S.A. (ES) | 2009-12-10 | — | — | US | claimed |
| US-20090076140-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES | ITALFARMACO, S. A. (ES) | 2009-03-19 | — | — | US | claimed |
| EP-1994929-A1 | USE OF DERIVATIVES OF NAPHTHALENESULPHONIC OR QUINOLINESULPHONIC ACID IN THE TREATMENT OF VASOPROLIFERATIVE OCULAR DISEASES | ITALFARMACO, S.A. (ES) | 2008-11-26 | — | — | EP | claimed |
| US-20060160849-A1 | Pharmaceutical compositions containing sulphonic acid derivatives | ITALFARMACO, S.A. (ES) | 2006-07-20 | — | — | US | claimed |
| EP-1602644-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES | Italfarmaco, S.A. (ES) | 2005-12-07 | — | — | EP | claimed |
| EP-1021483-B1 | WATER-REDISPERSIBLE FILM-FORMING POLYMER POWDERS PREPARED FROM ETHYLENICALLY UNSATURATED MONOMERS AND CONTAINING NAPHTHALENESULPHONATES | RHODIA CHIMIE SA (FR) | 2004-04-07 | — | — | EP | claimed |
| US-6391952-B1 | ETHYLENIC UNSATURATED MONOMER FORMING WATER INSOLUBLE FILMS | RHODIA CHIMIE (FR) | 2002-05-21 | — | — | US | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| JP-11189736-A | — | — | None | — | — | JP | disclosed |
| US-12564546-B2 | Self-tanning compositions containing an aromatic sulfonate and methods thereof | KAO CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| CN-119368337-A | Copper-molybdenum collector and preparation method and application thereof | 昆明冶金研究院有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-115485240-B | Sun-blocking compositions containing alkyl sulfonates and methods thereof | 花王株式会社 | 2024-12-27 | — | — | CN | disclosed |
| EP-0254294-A2 | Method of processing a silver halide color photographic material and a color developer | FUJI PHOTO FILM CO., LTD. (JP) | 1988-01-27 | — | — | EP | disclosed |
| EP-0242420-A1 | A toner for developing electrostatic latent images and a use thereof | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1987-10-28 | — | — | EP | disclosed |
| US-4560746-A | MONOAZO DYES, 2-(2-QUINOLYL)-1,3-INDANEDIONESULFONIC ACID | THE HILTON-DAVIS CHEMICAL CO. (US) | 1985-12-24 | — | — | US | disclosed |
| US-4234483-A | COLORFASTNESS; BRIGHTNESS | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306132-A1 | USE OF DERIVATIVES OF NAPHTHALENESULPHONIC OR QUINOLINESULPHONIC ACID IN THE TREATMENT OF VASOPROLIFERATIVE OCULAR DISEASES | NQO2, SQLE, SQOR | TTR 2000/4885AURKA 2675/4885AURKB 2377/4885 |
| US-20090076140-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES | SUCNR1, NR1H4, CYP2B6 | TTR 2283/4885AURKA 2667/4885AURKB 2526/4885 |
| US-20060160849-A1 | Pharmaceutical compositions containing sulphonic acid derivatives | SUCNR1, NR1H4, CYP2B6 | TTR 2247/4885AURKA 2648/4885AURKB 2509/4885 |
| US-12564546-B2 | Self-tanning compositions containing an aromatic sulfonate and methods thereof | CUTA, TYR, TREH | TTR 739/4885AURKA 3962/4885AURKB 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.